Literature DB >> 15264977

Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients.

Carolyn Rabin1, Howard Leventhal, Susan Goodin.   

Abstract

A sample of 69 breast cancer patients was assessed before and after cessation of treatment to determine the predictors of posttreatment distress. Patients were assessed approximately 6 weeks before completing chemotherapy treatment, 1 month after completing treatment, and 3 months after completing treatment. Results indicate that timeline beliefs are related to distress: Patients who conceptualize their cancer as a chronic or cyclic illness are more anxious, depressed, and worried about a recurrence than patients who conceptualize their cancer as an acute illness. These findings hold true even while controlling for disease stage. The way patients conceptualize their illness appears to be more influential in determining levels of posttreatment distress than objective indicators of the likelihood of recurrence. Copyright 2004 American Psychological Association

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15264977     DOI: 10.1037/0278-6133.23.4.407

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  20 in total

Review 1.  Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation.

Authors:  Joanna E Fardell; Belinda Thewes; Jane Turner; Jemma Gilchrist; Louise Sharpe; Allan 'Ben' Smith; Afaf Girgis; Phyllis Butow
Journal:  J Cancer Surviv       Date:  2016-01-19       Impact factor: 4.442

Review 2.  Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies.

Authors:  Sébastien Simard; Belinda Thewes; Gerry Humphris; Mélanie Dixon; Ceara Hayden; Shab Mireskandari; Gozde Ozakinci
Journal:  J Cancer Surviv       Date:  2013-03-10       Impact factor: 4.442

3.  Representations of cancer recurrence risk, recurrence worry, and health-protective behaviours: an elaborated, systematic review.

Authors:  Arturo Durazo; Linda D Cameron
Journal:  Health Psychol Rev       Date:  2019-06-03

4.  Understanding surgery choices for breast cancer: how might the Theory of Planned Behaviour and the Common Sense Model contribute to decision support interventions?

Authors:  Stephanie Sivell; Adrian Edwards; Glyn Elwyn; Antony S R Manstead
Journal:  Health Expect       Date:  2011-03       Impact factor: 3.377

5.  Measuring pain impact versus pain severity using a numeric rating scale.

Authors:  Liana Fraenkel; Paul Falzer; Terri Fried; Minna Kohler; Ellen Peters; Robert Kerns; Howard Leventhal
Journal:  J Gen Intern Med       Date:  2011-11-12       Impact factor: 5.128

6.  Anxiety and depression in Spanish-speaking Latina cancer patients prior to starting chemotherapy.

Authors:  Morgan S Lee; Dinorah Martinez Tyson; Brian D Gonzalez; Brent J Small; Suzanne C Lechner; Michael H Antoni; Andrea Vinard; Madeline Krause; Cathy Meade; Paul B Jacobsen
Journal:  Psychooncology       Date:  2017-07-13       Impact factor: 3.894

7.  The relationship between threat appraisal and social constraints in cancer survivors and their spouses.

Authors:  Michele Herzer; Sandra G Zakowski; Robert Flanigan; Peter Johnson
Journal:  J Behav Med       Date:  2006-09-02

8.  Breast self-examination in long-term breast cancer survivors.

Authors:  Peter C Trask; Lynne Pahl; Melinda Begeman
Journal:  J Cancer Surviv       Date:  2008-09-23       Impact factor: 4.442

Review 9.  Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine.

Authors:  M Bryant Howren; Alan J Christensen; Lucy Hynds Karnell; Gerry F Funk
Journal:  J Consult Clin Psychol       Date:  2012-09-10

10.  Illness cognitions in head and neck squamous cell carcinoma: predicting quality of life outcome.

Authors:  Margreet Scharloo; Robert J Baatenburg de Jong; Ton P M Langeveld; Els van Velzen-Verkaik; Margreet M Doorn-Op den Akker; Adrian A Kaptein
Journal:  Support Care Cancer       Date:  2009-08-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.